CBD Stocks

Sparkling CBD Launches First CBD Water

Sparkling CBD Launches First CBD Water

DENVER, Sept. 30, 2020 /PRNewswire/ — With a trusted lineup of all-natural CBD sodas already on the market, founders Moose Koons and Andrew Fulton would like to introduce you to the first CBD waters in the Sparkling CBD line up. Introductory flavors include...

Meet The Entrepreneur Building A Global CBD Brand From The UK

Meet The Entrepreneur Building A Global CBD Brand From The UK

Britain’s cannabidiol (CBD) market has accelerated at a remarkable pace. Starting from standstill three years ago when regulators reclassified CBD as a medicine, it is now worth £300m a year according to research from Savills, and sales are on target to hit £1bn by...

CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge

You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.

Major Hemp CBD Expo Returns to Dallas

Major Hemp CBD Expo Returns to Dallas

DALLAS, June 16, 2021 /PRNewswire/ — Lucky Leaf Expo is coming back to Dallas for its second annual Hemp CBD Expo. With the passing of House Bill 1325 Texas is poised to be the largest Hemp producing state in the nation. With over 1,500 licenses and over...

10 Pot Stocks Expected to Be Profitable in 2021

10 Pot Stocks Expected to Be Profitable in 2021

Although all eyes have been on work-from-home stocks over the past couple of months, Wall Street may be ignoring one of the fastest-growing industries on the planet over the next decade: marijuana. In the U.S. alone, legal weed sales could triple between 2019 and...

Investor buzz around cannabis stocks with new treatments

Investor buzz around cannabis stocks with new treatments

Last week ASX-listed Zelira Therapeutics, formerly Zelda Therapeutics, scored a new substantial shareholder when billionaire investor Alex Waislitz’s Thorney Investment Group upped its stake from 2 per cent to 5.2 per cent. Earlier this month Zelira confirmed...